Potent inhibitor of Kv1.5 potassium channel

Novel Potent and Stable Antagonist of the Human α9α10 Nicotinic Acetylcholine Receptor for the Treatment of Neuropathic Pain

Orally active, selective dopamine D3 receptor partial agonist

Novel peptide-drug conjugate, inducing significant tumor growth suppression with negligible toxicity

Novel avß6 selective arginyl-glycinyl-aspartic acid (RGD)-mimetic, demonstrating to bind with extremely high affinity and selectivity for the alphavß6 integrin and having the potential as a clinical tool and therapeutic for investigating the role of avß6

Potent, selective & ATP-competitive inhibitor of Cdks

Highly Potent Clickable Probe for Cellular Imaging of MDM2 and Assessing Dynamic Responses to MDM2-p53 Inhibition

Gene switch ligand as a transcription inducer for use in induceable gene expression systems

Novel fluorescent D-amino acid for labeling peptidoglycans (PG) in live bacteria

Novel Highly Selective Neuropeptide FF1 Receptor Antagonist, Potently Preventing Opioid-Induced Hyperalgesia

Novel TLR2 activator

Novel biomediator that induces reveromycins production at the wide range of concentrations without affecting cell growth

Novel phosphodiesterase IV (PDE4) inhibitor for the treatment of Asthma and Rheumatoid Arthritis

Novel inhibitor of the REV1/UbPCNA interaction, directly binding to REV1 UBM2 and preventing DNA damage tolerance (DDT)

Novel potent inhibitor of EBOV infection and entry

Metabolite of Resveratrol

Metabolite of Resveratrol

Red-absorbing, water-soluble, and iodinated resorufin derivative, being selectively activated with a monoamine oxidase (MAO) enzyme, showing high 1O 2 generation yields in aqueous solutions upon addition of MAO isoforms

Angiotensin-converting enzyme 2 (ACE2) activator, acting as a modulator on RAAS and KKS activation during COVID-19

Potent VR1 vanilloid receptor agonist, activating protein kinase C

Oxidation-reduction indicator in cell viability

Selective 5-HT1A receptor agonist

Novel bacterial methionyl t-​RNA synthetase (MRS) inhibitor, hampering Plasmodium growth very effectively

5-HT3 antagonist and 5-HT4 agonist, also acting as a 5-HT2B antagonist

Potent ultra short-acting synthetic unique opioid analgesic

Novel selective antagonist of the mGlu5 receptor

Novel specific inhibitor of the ability of RegA to activate its target promoters, reducing expression of a number of proteins required for virulence

Novel inhibitor of the supercoiling and ATPase reactions of DNA gyrase, inhibiting gyrase by preventing the binding of ATP and showing selectivity against M. smegmatis.

Novel potent inhibitor of the supercoiling and ATPase reactions of DNA gyrase, inhibiting gyrase by preventing the binding of ATP

Novel Prenyltransferase Inhibitor with In Vitro and In Vivo Antibacterial Activity